IDEAYA Biosciences Inc (IDYA)
40.51
-1.02
(-2.46%)
USD |
NASDAQ |
May 17, 16:00
40.51
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Total Liabilities (Quarterly): 26.22M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.22M |
| December 31, 2023 | 28.23M |
| September 30, 2023 | 24.89M |
| June 30, 2023 | 25.95M |
| March 31, 2023 | 30.94M |
| December 31, 2022 | 38.51M |
| September 30, 2022 | 42.14M |
| June 30, 2022 | 68.69M |
| March 31, 2022 | 70.20M |
| December 31, 2021 | 79.83M |
| September 30, 2021 | 81.82M |
| Date | Value |
|---|---|
| June 30, 2021 | 88.14M |
| March 31, 2021 | 92.97M |
| December 31, 2020 | 100.00M |
| September 30, 2020 | 105.96M |
| June 30, 2020 | 12.45M |
| March 31, 2020 | 12.69M |
| December 31, 2019 | 12.60M |
| September 30, 2019 | 11.92M |
| June 30, 2019 | 12.75M |
| March 31, 2019 | 12.35M |
| December 31, 2018 | 145.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.92M
Minimum
Sep 2019
105.96M
Maximum
Sep 2020
48.34M
Average
34.72M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 65.42B |
| Pfizer Inc | 128.54B |
| Geron Corp | 137.21M |
| Verastem Inc | 77.32M |
| Karyopharm Therapeutics Inc | 373.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 961.53M |
| Shareholders Equity (Quarterly) | 935.31M |